How quickly do you feel the effects of Wegovy?

What clinical trials actually recorded about early effects

The STEP 1 trial, published in the New England Journal of Medicine, followed over 1,900 adults with obesity or overweight for 68 weeks. Participants on semaglutide 2.4 mg lost an average of around 15% of their body weight by the end of the study. That headline number, though, tells you almost nothing about the timeline. The weight loss didn't arrive in one go. Participants reported changes in hunger and fullness relatively early, often within the first couple of weeks. Measurable weight reduction was already visible on the scales by weeks four to eight for most people. The bulk of the loss, however, accumulated steadily across the full titration period and beyond.

This phased pattern makes biological sense. Semaglutide works by activating GLP-1 receptors involved in appetite signalling and gastric emptying, and the dose starts low specifically to let your system adjust. The 0.25 mg starting dose isn't where the therapeutic action is strongest. Each step up, taken roughly every four weeks under your prescriber's guidance, tends to sharpen the effect a little further. You can read more about how long Wegovy takes to work across the full treatment course if you want a closer look at the longer arc.

The first few weeks: what people tend to notice first

For many people, the first sign that something has changed is not the number on the scales. It's smaller portions feeling satisfying. It's remembering at lunchtime that you haven't thought about breakfast. Nausea is also common in the early weeks, particularly after a dose increase, and that alone can reduce how much you eat. The NHS semaglutide medicines page lists nausea, vomiting, diarrhoea and constipation as the most frequently reported early side effects, generally described as mild to moderate and settling over time.

It's worth being honest here: some people don't notice much at all in the first four weeks, especially at 0.25 mg. That's expected. The starting dose exists to settle your system, not to produce rapid weight loss. If you're timing your first pen around a holiday, or you've started just after payday so the routine feels disrupted, try not to read the first few weeks as a verdict on whether the treatment is working. If you're wondering how long until you feel the effects of Wegovy, the evidence says the curve comes later.

If you're curious about the very earliest effects specifically, there's a detailed look at the first days and weeks on our how quickly you feel Wegovy page.

Longer-term effects and the role of dose increases

Weight loss with Wegovy isn't a sprint. The standard maintenance dose of 2.4 mg takes around five months to reach from the 0.25 mg start, assuming the recommended titration schedule. Results from STEP 1 showed that weight loss continued accumulating for most of that period and beyond. Many people asking how long to feel the effects of Wegovy are surprised to learn that the pace of loss tended to be fastest in the early maintenance phase and then gradually slowed as participants approached a new stable point.

The MHRA approved the higher 7.2 mg dose in January 2026, with dedicated single-dose pens confirmed in April 2026. Trial data for that dose reported average weight loss of around 20.7% over 72 weeks, again built over an extended titration arc, not front-loaded in the first month. Those wondering how long before they feel the effects of Wegovy will find this worth understanding when comparing it to other treatments, because the question isn't just what it does, but over what timeframe. For a fuller picture of pricing and what's involved in starting private treatment, our Wegovy prices page covers what an all-in private prescription typically includes.

One thing the evidence is consistent about: stopping early, before reaching maintenance and staying there for a meaningful period, produces much smaller results than completing the course. Continuous clinical support matters here. Our clinical team reviews your treatment at every repeat, not just at sign-up.

When to talk to your prescriber about your progress

NICE guidance and the Wegovy licence both reference a practical checkpoint: if you haven't lost at least 5% of your body weight after six months on the maintenance dose, your prescriber should review whether continuing makes sense. That benchmark is worth knowing, but it's a clinical threshold to discuss with a professional, not a DIY decision. Prescribers also look at tolerability, adherence, and what's been happening with dose changes when they make that assessment.

If you feel the effects have stalled, or side effects are making it hard to reach your maintenance dose, that's a conversation for your prescriber, not something to troubleshoot alone. A question our prescribers hear regularly is whether a slower titration might reduce nausea without sacrificing long-term results. The answer often depends on the individual. You can explore the broader range of weight-loss treatment options available through nume, or head directly to the consultation page to speak to our prescribers about whether Wegovy is clinically right for you.